Until CTSO releases their dosing studies their stock is going nowhere as their credibility is being questioned, since the studies are a year past due. Promised in 4Q of 2012. Two companies struggling to figure their life saving filter devices out. Just seems like a long road ahead for both. jmo
I agree with the dosing study delay and hopefully the interim data comes as has been indicated by year end. I follow both stocks, but i think that CTSO is a little ahead of AEMD in regards to commercialization with an ever expanding list of distributors throughout Europe, with the most recent deal with a distributor in Russia. Both of their technologies have merit and I think that shareholders in both companies will be rewarded providing they have the patience to see things through til the end.